Evidence map›Paper›PMID 34595190›Full record

ArticleFrontiers in medicine2021

Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients.

Jinan Guo, Xuhui Zhang, Taolin Xia, Heather Johnson, Xiaoyan Feng, Athanasios Simoulis, Alan H B Wu, Fei Li, Wanlong Tan, Allan Johnson and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jinan GuoShenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
Xuhui ZhangDepartment of Bio-diagnosis, Institute of Basic Medical Sciences, Beijing, China.
Taolin XiaDepartment of Urology, Foshan First People's Hospital, Foshan, China.
Heather JohnsonOlympia Diagnostics, Inc., Sunnyvale, CA, United States.
Xiaoyan FengDepartment of Bio-diagnosis, Institute of Basic Medical Sciences, Beijing, China.
Athanasios SimoulisDepartment of Clinical Pathology and Cytology, Skåne University Hospital, Malmö, Sweden.
Alan H B WuClinical Laboratories, San Francisco General Hospital, San Francisco, CA, United States.
Fei LiDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Wanlong TanDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Allan JohnsonKinetic Reality, Santa Clara, CA, United States.
Nishtman DizeyiDepartment of Translational Medicine, Clinical Research Centre, Lund University, Malmö, Sweden.
Per-Anders AbrahamssonDepartment of Translational Medicine, Clinical Research Centre, Lund University, Malmö, Sweden.
Lukas KennerDepartment of Experimental Pathology, Medical University Vienna & Unit of Laboratory Animal Pathology, University of Veterinary Medicine, Vienna, Austria.
Kefeng XiaoShenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
Heqiu ZhangDepartment of Bio-diagnosis, Institute of Basic Medical Sciences, Beijing, China.
Lingwu ChenDepartment of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Chang ZouShenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
Jenny L PerssonDepartment of Molecular Biology, Umeå University, Umeå, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

active surveillanceclinically significant prostate cancergene panelliquid biopsyprostate cancerprostate cancer riskurine test

Identifiers

PMID34595190
PMCPMC8476767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.